Akero Therapeutics Inc (AKRO)
43.29
-1.95
(-4.31%)
USD |
NASDAQ |
Mar 26, 16:00
43.10
-0.19
(-0.44%)
After-Hours: 04:19
Akero Therapeutics Max Drawdown (5Y): 79.99% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| 89bio Inc | 95.00% |
| Biogen Inc | 67.83% |
| Cytokinetics Inc | 61.54% |
| Sage Therapeutics Inc | 96.91% |
| Allakos Inc | 99.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 17.89 |
| Beta (5Y) | -0.1929 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 109.0% |
| Historical Sharpe Ratio (5Y) | 0.1388 |
| Historical Sortino (5Y) | 0.3156 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.77% |